The stock price of Septerna Inc (NASDAQ: SEPN) has dropped by -4.39 compared to previous close of 27.09. Despite this, the company has seen a gain of 15.57% in its stock price over the last five trading days. globenewswire.com reported 2024-12-18 that SOUTH SAN FRANCISCO, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) — Septerna, a clinical-stage biotechnology company pioneering a new era of GPCR-targeted drug discovery, today announced that Jeffrey Finer, M.D., Ph.D., chief executive officer and co-founder of Septerna, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 3:45 p.m. PT in San Francisco.
Is It Worth Investing in Septerna Inc (NASDAQ: SEPN) Right Now?
There are mixed opinions on the stock, with 3 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for SEPN is 31.06M, and at present, short sellers hold a 3.25% of that float. The average trading volume of SEPN on December 26, 2024 was 417.00K shares.
SEPN’s Market Performance
The volatility ratio for the week is 13.37%, and the volatility levels for the last 30 days are 9.74% for Septerna Inc (SEPN). The simple moving average for the past 20 days is 6.90% for SEPN’s stock, with a 9.82% simple moving average for the past 200 days.
Analysts’ Opinion of SEPN
Many brokerage firms have already submitted their reports for SEPN stocks, with Wells Fargo repeating the rating for SEPN by listing it as a “Overweight.” The predicted price for SEPN in the upcoming period, according to Wells Fargo is $43 based on the research report published on November 19, 2024 of the current year 2024.
JP Morgan gave a rating of “Overweight” to SEPN, setting the target price at $38 in the report published on November 19th of the current year.
SEPN Trading at 9.82% from the 50-Day Moving Average
After a stumble in the market that brought SEPN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -10.66% of loss for the given period.
Volatility was left at 9.74%, however, over the last 30 days, the volatility rate increased by 13.37%, as shares surge +11.40% for the moving average over the last 20 days.
During the last 5 trading sessions, SEPN rose by +15.57%, in comparison to the 20-day moving average, which settled at $24.23. In addition, Septerna Inc saw 21.03% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SEPN starting from RA CAPITAL MANAGEMENT, L.P., who purchase 4,170,000 shares at the price of $18.00 back on Oct 28 ’24. After this action, RA CAPITAL MANAGEMENT, L.P. now owns 5,523,915 shares of Septerna Inc, valued at $75,060,000 using the latest closing price.
Third Rock Ventures V, L.P., the 10% Owner of Septerna Inc, purchase 370,500 shares at $18.00 during a trade that took place back on Oct 28 ’24, which means that Third Rock Ventures V, L.P. is holding 6,215,591 shares at $6,669,000 based on the most recent closing price.
Stock Fundamentals for SEPN
The liquidity ratio also appears to be rather interesting for investors as it stands at 10.08.
Conclusion
In summary, Septerna Inc (SEPN) has had a better performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
